Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Obesity and Obesity-related Medical Conditions
Open-data reference.
14 US clinical trials · 13 currently recruiting
Active & Recent Trials
Advancing Biopsychosocial Care Training Initiative
Washington University School of Medicine
NCT07049861
A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
Metsera, a wholly owned subsidiary of Pfizer
NCT06924320
Bariatric Surgery vs. Semaglutide vs. Tirzepatide
Ali Aminian
NCT06803888
Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss
Boston Scientific Corporation
NCT06894498
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
Bettina Mittendorfer
NCT07083557
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
Brown University
NCT06948058
New Mechanisms of Obesity
Yale University
NCT06768827
2024 Tirzepatide-Bariatric Surgery
Marlene Starr
NCT06721507
Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia
University of Tennessee Graduate School of Medicine
NCT06802861
Randomized Control Trial of Sleeve Gastrectomy with Tirzepatide in Maximizing Weight Loss
Nicholas Skertich
NCT06734273
MAINTAIN (Mucosal AblatIoN Therapy After INcretins)
Dr. Christopher McGowan
NCT06734312
UTSW NORC Pilot Spinal Cord Injury Dietary Program
University of Texas Southwestern Medical Center
NCT06924177
REvision of VSG with Ablation of the Mucosa Procedure
Dr. Christopher McGowan
NCT06671119
NUTRITION MATTERS: A Food is Medicine Intervention for African-American Adults With Multiple Chronic Conditions
Winston Salem State University
NCT06933940
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 2 |
| Phase 4 | 2 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Obesity and Obesity-related Medical Conditions Trial Landscape
ClinicalTrials.gov lists 14 US studies indexed under Obesity and Obesity-related Medical Conditions, and 13 of those are currently open to recruitment — roughly 93% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Obesity and Obesity-related Medical Conditions shows 2 late-stage studies (Phase 3 and Phase 4 combined) alongside 2 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Obesity and Obesity-related Medical Conditions is led by Dr. Christopher McGowan with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 14 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Obesity and Obesity-related Medical Conditions?
PlainTrial tracks 14 US clinical trials for Obesity and Obesity-related Medical Conditions, of which 13 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Obesity and Obesity-related Medical Conditions?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.